Cargando…
Assessing Cachexia Acutely after Autologous Stem Cell Transplant
Autologous hematopoietic stem cell transplantation (AHCT) is an accepted strategy for various hematologic malignancies that can lead to functional impairment, fatigue, muscle wasting, and reduced quality of life (QOL). In cancer cachexia, these symptoms are associated with inflammation, hypermetabol...
Autores principales: | Anderson, Lindsey J., Yin, Chelsea, Burciaga, Raul, Lee, Jonathan, Crabtree, Stephanie, Migula, Dorota, Geiss-Wessel, Kelsey, Liu, Haiming M., Graf, Solomon A., Chauncey, Thomas R., Garcia, Jose M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769803/ https://www.ncbi.nlm.nih.gov/pubmed/31487803 http://dx.doi.org/10.3390/cancers11091300 |
Ejemplares similares
-
SUN-230 Association of Estrogens and Androgens with Sexual Function after Hematopoietic Stem Cell Transplant
por: Anderson, Lindsey, et al.
Publicado: (2019) -
Muscle mass, not radiodensity, predicts physical function in cancer patients with or without cachexia
por: Anderson, Lindsey J., et al.
Publicado: (2020) -
Autologous hematopoietic transplantation following COVID‐19 infection
por: Brzycki, Marthilde, et al.
Publicado: (2021) -
Mantle cell lymphoma relapsed after autologous stem cell transplantation: a single-center experience
por: Wu, Aaron, et al.
Publicado: (2020) -
Pilot clinical trial of macimorelin to assess safety and efficacy in patients with cancer cachexia
por: Herodes, Megan, et al.
Publicado: (2023)